title: The tobacco use management system: analyzing tobacco control from a systems perspective.
abstract: We use systems thinking to develop a strategic framework for analyzing the tobacco problem and we suggest solutions. Humans are vulnerable to nicotine addiction, and the most marketable form of nicotine delivery is the most harmful. A tobacco use management system has evolved out of governments' attempts to regulate tobacco marketing and use and to support services that provide information about tobacco's harms and discourage its use. Our analysis identified 5 systemic problems that constrain progress toward the elimination of tobacco-related harm. We argue that this goal would be more readily achieved if the regulatory subsystem had dynamic power to regulate tobacco products and the tobacco industry as well as a responsive process for resourcing tobacco use control activities.
authors.affiliation: VicHealth Centre for Tobacco Control, Cancer Council Victoria, Victoria, Australia. ron.borland@cancervic.org.au
authors.forename: Ron
authors.initials: R
authors.lastname: Borland
authors.forename: David
authors.initials: D
authors.lastname: Young
authors.forename: Ken
authors.initials: K
authors.lastname: Coghill
authors.forename: Jian Ying
authors.initials: JY
authors.lastname: Zhang
mesh_terms: D006801:Humans; D000074606:Smoking Prevention; D011049:Social Control Policies / Q000331:legislation & jurisprudence*; D013597:Systems Analysis; D013598:Systems Theory; D019460:Tobacco Industry / Q000331:legislation & jurisprudence*; D014029:Tobacco Use Disorder / Q000517:prevention & control*
references.citation: Am J Public Health. 2008 Sep;98(9):1630-42
references.pmid: 18633079
references.citation: Global Health. 2008 Jan 17;4:2
references.pmid: 18201375
references.citation: Drug Alcohol Rev. 2008 Jan;27(1):21-7
references.pmid: 18034378
references.citation: Nicotine Tob Res. 2008 May;10(5):907-15
references.pmid: 18569766
references.citation: J Public Health (Oxf). 2009 Mar;31(1):3-10
references.pmid: 19109341
references.citation: Tob Control. 2003 Dec;12(4):349-59
references.pmid: 14660766
references.citation: Tob Control. 2003 Mar;12(1):60-6
references.pmid: 12612364
references.citation: Aust N Z J Public Health. 2007 Apr;31(2):164-9
references.pmid: 17461008
references.citation: Am J Public Health. 2006 Mar;96(3):538-46
references.pmid: 16449581
references.citation: Am J Public Health. 2006 Mar;96(3):403-5
references.pmid: 16449572
references.citation: J Pediatr Hematol Oncol. 2005 Oct;27(10):543-50
references.pmid: 16217258
references.citation: Tob Control. 2006 Aug;15(4):339-40
references.pmid: 16885584
references.citation: Tob Control. 2003 Dec;12(4):374-82
references.pmid: 14660771
references.citation: Am J Public Health. 2010 Jul;100(7):1208-17
references.pmid: 20466949
references.citation: Lancet. 2008 Feb 2;371(9610):441-5
references.pmid: 17920116
references.citation: Am J Public Health. 2006 Mar;96(3):473-9
references.pmid: 16449586
references.citation: BMJ. 2000 Aug 5;321(7257):371-4
references.pmid: 10926602
references.citation: Tob Control. 2008 Jun;17(3):211-4
references.pmid: 18339800